Non-Invasive Biomarkers of NASH

The following publication discusses the latest research regarding the Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis (NASH).  Nature Medicine originally published this article, coauthored by ERG’s Vice President of Clinical Pharmacology Services Clay Dehn, on February 10th, 2022. This browser does not support PDFs. Please download the PDF to view it: Download PDF.

STUDIES ARE ENROLLING NOW!

Bipolar Disorder

Living with Bipolar Disorder? A Clinical Trial May Be An Option. Learn more today!

Opioid Addiction

Struggling with opioid use disorder? Learn more about a clinical trial.


Depression

Qualified participants may see a physician or medical staff at no cost and may receive compensation for time and travel.